HealthEquity account plan
Health savings account administration
At a glance
HealthEquity administers 10.7 million health savings accounts and other benefits in the US; FY2026 revenue was $1,313.4 million.
HealthEquity (NASDAQ: HQY, Draper, Utah) administers tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits such as FSAs, HRAs, COBRA and commuter programs. It reaches members through employer Clients, benefits brokers, more than 200 Network Partners and a direct sales force, and is the largest HSA provider by accounts and second largest by assets, with 20% of HSA Assets. FY2026 (year ended January 31, 2026) revenue was $1,313.4 million (+9%), net income $215.2 million and Adjusted EBITDA $566.0 million. It operates only in the US, as a single segment, with 2,814 team members.
Business units
Custodial revenue
about 48% of FY2026 revenue ($636.8 million)Interest earned on HSA cash placed with insurance company partners (Enhanced Rates) and Depository Partners, and on Client-held funds. It grew 17% in FY2026 as the HSA cash yield rose from 3.11% to 3.53%, and rose to 3.83% in Q2 FY2027.
Service revenue
about 37% of FY2026 revenue ($485.0 million)Administration fees for HSAs and CDBs, fees on invested HSA Assets and marketplace revenue. It grew only 1% in FY2026 as lower average fees per account offset growth, then 6% in Q2 FY2027 helped by the marketplace.
Interchange revenue
about 15% of FY2026 revenue ($191.6 million)Merchant fees when members pay with HealthEquity cards or the virtual payment system. It grew 9% in FY2026 on more accounts and higher spend per account.
Strategic priorities
- Building a healthcare financial operating system
- CEO Scott Cutler plans to connect accounts, assets, payments, investing, marketplace and advisory in one experience, driven by account and asset growth, deeper engagement and AI-enabled efficiency.
- Capturing newly HSA-eligible consumers
- The July 2025 law opened HSAs to Bronze and Catastrophic plans, about a 10% expansion of potential accounts; the company is building a direct enrollment platform and new retail muscle in the individual and family plan market.
- AI-enabled service efficiency
- AI resolved 85% of routine chat inquiries and human-handled calls fell 25%; the next phase targets client services and back office claims automation.
- Growing the marketplace
- Launched in Q4 FY2026 with weight-loss programs, hormone replacement therapy and wearables; it had more than 14,000 active members, with sleep, health vision and pediatric care categories planned.
- Raising custodial yield
- Enhanced Rates is heading toward about 80% of HSA cash, from 58% at year end; the FY2027 HSA cash yield is expected at 3.85% to 3.9%, with $3 billion of forward contracts locking a five-year Treasury rate near 3.9%.
Latest results
In Q2 FY2027 (three months to July 31, 2026), revenue was $350.7 million (+8%), net income $65.6 million (+10%) and Adjusted EBITDA $167.0 million (+11%), a record 48% margin. HSAs reached 10.7 million (+8%) with $37.9 billion of HSA Assets (+14%), and new HSAs from sales grew 24%. For the first half, revenue was $705.4 million (+7%) and net income $135.1 million (+19%). FY2027 guidance was raised to revenue of $1.411 billion to $1.421 billion, net income of $242 million to $248 million and Adjusted EBITDA of $628 million to $636 million.
Investments and deals
- Technology modernization
- Capex was $48.5 million in FY2026 and is to stay at that level in FY2027 for system architecture; technology and development spending rose 14% in Q2 FY2027 on software and cloud infrastructure.
- Next-generation app
- A new app merging the HealthEquity app with the EZ Receipts reimbursement app is due in the coming months; the app had 1.4 million monthly active users in July 2026.
- Share buybacks and debt paydown
- $299.3 million of buybacks and a $100.0 million debt prepayment in FY2026, then $231.1 million of buybacks in the first half of FY2027, with $948.4 million still authorized.
- HSA portfolio acquisitions
- Selective purchases of HSA portfolios from competitors that see HSAs as non-core, such as BenefitWallet from Conduent ($425.0 million), with integration of the Further acquisition still under way.
Challenges and risks
- Admin fee price erosion
- Lower average service fees per account offset account growth in FY2026; the CFO acknowledged headline price erosion in admin fees.
- Interest-rate sensitivity
- Custodial revenue, about half of revenue, depends on yields on HSA cash, so lower interest rates would reduce it.
- Fraud and cyber risk
- Fraud on member accounts has caused financial and reputational damage; fraud cost was about 1.1 basis points in FY2026 against a target of one basis point.
- Competition and partner dependence
- Competitors include Fidelity, Optum and Webster Bank, and Network Partners may switch providers or offer competing services.
What leadership says
“Q1 demonstrated that the model is scaling, and Q2 showed that the model is becoming more durable”
“AI is becoming an earnings engine for HealthEquity, Inc.”
“The policy environment for HSAs is the most constructive it has been in two decades.”
“Mobile is increasingly the front door of member engagement.”
Where a supplier can help
- Consumer acquisition for the retail channel
- Tied to capturing newly HSA-eligible consumers: digital marketing, broker and exchange partners can feed the direct enrollment platform aimed at Bronze-plan members.
- AI for client services and back office
- Tied to AI-enabled service efficiency: claims automation, onboarding and document-processing tools fit the next phase after member services.
- Marketplace providers
- Tied to growing the marketplace: healthcare product and program providers in planned categories such as sleep, vision and pediatric care can reach members through it.
- Fraud prevention and security
- Tied to the fraud and cyber challenge: authentication and fraud detection vendors support a company already spending more on fraud prevention.
- Cloud and mobile engineering
- Tied to technology modernization and the next-generation app: cloud infrastructure and mobile development partners fit rising technology and development spend.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like HealthEquity?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Form 10-K for the fiscal year ended January 31, 2026
- HealthEquity is a US technology-enabled administrator of health savings accounts (HSAs) and other consumer-directed benefits (CDBs: FSAs, HRAs, COBRA, commuter); as of January 31, 2026 it administered 10.6 million HSAs with $36.5 billion of HSA Assets plus 7.2 million CDBs, 17.8 million Total Accounts in all.
- Market position: HSA market share by assets rose from 4% (December 2010) to 20% (June 2025); per Devenir it is the largest HSA provider by accounts and second largest by assets, and believes it is the largest provider of other CDBs.
- FY2026 (year ended January 31, 2026) revenue was $1,313.4 million, up 9%: service $485.0 million (+1%), custodial $636.8 million (+17%), interchange $191.6 million (+9%).
- Net income rose 123% to $215.2 million ($2.46 per diluted share); Adjusted EBITDA rose 20% to $566.0 million, 43% of revenue (39% the year before).
- B2B2C distribution: reaches members through employer Clients, benefits brokers, more than 200 integrated Network Partners (health plans, benefits administrators, retirement recordkeepers) and a direct sales force; single operating segment, US only, 2,814 team members.
- Custodial yield on HSA cash rose from 3.11% to 3.53%, helped by Enhanced Rates (insurance-company placements) growing from 49% to 58% of HSA cash; $17.3 billion of HSA cash reprices on a schedule at a 3.6% average yield.
- Priorities: technology modernization and growing use of AI (Expedited Claims, HSAnswers), a new healthcare marketplace, campaigns aimed at people newly HSA-eligible under the July 2025 "One Big Beautiful Bill Act" (Bronze and Catastrophic plans), and selective HSA portfolio acquisitions.
- Capital: $299.3 million of buybacks and a $100.0 million debt prepayment in FY2026; $361.9 million drawn on a $1.0 billion revolver plus $600 million of 4.50% Senior Notes due 2029; capex $48.5 million.
- Main risks: changes to HSA tax benefits, interest-rate declines, failure of insurance or Depository Partners, cyber attacks and member-account fraud, competition from Fidelity, Optum and Webster Bank, and dependence on Network Partners.
- Form 10-Q for the quarter ended July 31, 2026 (Q2 fiscal 2027)
- Q2 FY2027 (three months to July 31, 2026): revenue $350.7 million (+8%); service $124.4 million (+6%), custodial $175.9 million (+10%), interchange $50.4 million (+5%).
- First half: revenue $705.4 million (+7%), net income $135.1 million (+19%), Adjusted EBITDA $331.5 million (+14%, 47% of revenue).
- Quarterly net income was $65.6 million (+10%) and Adjusted EBITDA $167.0 million (+11%, 48% margin against 46%).
- 10.7 million HSAs (+8%) with $37.9 billion of HSA Assets (+14%); HSA investments +28% to $20.6 billion; new HSAs from sales +24% in the quarter; CDBs fell 2% to 7.0 million.
- The yield on HSA cash rose to 3.83% (from 3.51%), with more Enhanced Rates placements and higher-yield deposits; marketplace revenue now drives service-revenue growth.
- Cost of revenue fell to 27.1% of revenue in the half (from 30.4%) on technology efficiencies and less fraud; technology and development rose 14% in the quarter (software and cloud infrastructure).
- Capital: $231.1 million of buybacks in the half and a $26.9 million debt prepayment; $335.0 million drawn on the revolver; $948.4 million of repurchase authority remaining.
- HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results (press release)
- Q2 FY2027 results release (August 27, 2026): revenue $350.7 million (+8%), net income $65.6 million (+10%), Adjusted EBITDA $167.0 million (+11%), Adjusted EBITDA margin 48% (46% a year earlier).
- Net income per diluted share was $0.78 (from $0.68); non-GAAP net income per diluted share rose 15% to $1.24.
- HSAs reached 10.7 million (+8%), 0.9 million of them with investments (+20%); Total HSA Assets were $37.9 billion (+14%); new HSAs from sales were 202 thousand (+24%).
- FY2027 guidance raised: revenue of $1.411 billion to $1.421 billion, net income of $242 million to $248 million ($2.88 to $2.96 per share), Adjusted EBITDA of $628 million to $636 million.
- Non-GAAP net income guidance of $392 million to $398 million ($4.66 to $4.73 per share, on about 84 million shares).
- Capital return: 1.2 million shares bought back for $108.1 million in the quarter; $948.4 million still authorized.
- CEO Scott Cutler called it "a record-setting second quarter" and said the momentum "gives us confidence to raise fiscal 2027 guidance".
- HealthEquity Q2 fiscal 2027 earnings call transcript
- CEO Scott Cutler: "Q1 demonstrated that the model is scaling, and Q2 showed that the model is becoming more durable"; strategy is to evolve the platform into "a healthcare financial operating system" spanning accounts, payments, investing, marketplace and advisory.
- New HSAs from sales grew 24%, a Q2 record and the strongest quarter outside Q4 open enrollment; client renewals are on pace to be "well above 90%" for the year.
- Engagement: 1.4 million monthly app users in July (+62%), more than 5 million downloads; a next-generation app that also folds in the EZ Receipts reimbursement app is due "in the coming months".
- Marketplace had more than 14,000 active members; categories now span metabolic and hormonal health, diagnostics, devices, skincare and recovery; non-metabolic programs are about a third of marketplace revenue; Health Savings Days drew 500,000 unique visitors in a week.
- AI resolved 85% of routine chat inquiries and contained 55% of card-related phone contacts; human-handled calls fell 25% year over year; efforts now move to client services and back office.
- CFO James Lucania: gross profit $258 million, about 74% of revenue; FY2027 HSA cash yield expected at 3.85% to 3.9%; $3 billion of forward contracts lock a five-year Treasury rate near 3.9%; first hedges placed on Enhanced Rates repricings.
- Lucania flagged "headline price erosion" in admin fees as a headwind; buybacks continue (about $948 million left of a $1.6 billion cumulative authorization), and an Investor Day is set for April 13, 2027.
- HealthEquity Q4 fiscal 2026 earnings call transcript
- CEO Scott Cutler called fiscal 2026 "a year of accelerating earnings power": a record 550,000 HSAs added in Q4, more than 1,000,000 new HSAs from sales in the year, Q4 Adjusted EBITDA +23%.
- Q4 revenue was $334.6 million (+7%); Q4 gross margin rose to 68% from 61% as fraud reimbursements fell to about $300,000 in the quarter.
- Strategy is a save-spend-invest "flywheel"; the marketplace launched in Q4 with weight-loss programs, hormone replacement therapy and wearables, categories put at more than $100 billion of spend.
- AI is embedded in three ways (member experience, operating efficiency, personalization at scale); Cutler: "AI is becoming an earnings engine".
- Vice Chair Steve Neeleman called the HSA policy environment "the most constructive it has been in two decades" after Bronze ACA exchange plans became HSA-eligible; Cutler put the expansion at about 10% of the market in potential accounts.
- Initial FY2027 guidance: revenue of $1,405,000,000 to $1,415,000,000, Adjusted EBITDA of $618,000,000 to $628,000,000, HSA cash yield about 3.8%.
- CFO James Lucania expects Enhanced Rates to reach about 80% of HSA cash, after which the HSA cash yield should track the ten-year moving average of the five-year Treasury; revenue retention was above 98%.
Questions about HealthEquity
What does HealthEquity do?
HealthEquity administers health savings accounts and other consumer-directed benefits such as FSAs, HRAs, COBRA and commuter programs, mostly offered through employers.
What is HealthEquity's revenue?
FY2026 revenue (year ended January 31, 2026) was $1,313.4 million, up 9%. FY2027 revenue is guided at $1.411 billion to $1.421 billion.
How many employees does HealthEquity have?
HealthEquity had 2,814 team members at January 31, 2026, most of them working remotely.
Who leads HealthEquity?
Scott Cutler is President and CEO, James Lucania is EVP and CFO, Robert Selander is Chairman and founder Dr. Steve Neeleman is Vice Chair.
How many HSAs does HealthEquity manage?
It managed 10.7 million HSAs with $37.9 billion of HSA Assets at July 31, 2026, and 17.8 million Total Accounts including other benefits.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)